{"id":"https://openalex.org/W39034895","doi":null,"title":"Abstract 1581: Patient Compliance With Single Pill, Dual and Triple Antihypertensive Combinations","display_name":"Abstract 1581: Patient Compliance With Single Pill, Dual and Triple Antihypertensive Combinations","alternate_titles":[],"publication_year":2009,"publication_date":"2009-11-03","ids":{"openalex":"https://openalex.org/W39034895","mag":"39034895"},"language":"en","primary_location":{"id":"mag:39034895","doi":null,"is_oa":false,"landing_page_url":"http://circ.ahajournals.org/cgi/content/meeting_abstract/120/18_MeetingAbstracts/S522-a","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Circulation","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W39034895"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110234200","display_name":"Feride Frech\u2010Tamas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Feride Frech\u2010Tamas","raw_affiliation_strings":["Novartis Pharmaceuticals  Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals  Corporation, East Hanover, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056555796","display_name":"Winnie Zhang","orcid":"https://orcid.org/0009-0007-2215-3197","observed_orcids":["https://orcid.org/0009-0007-2215-3197"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Winnie Zhang","raw_affiliation_strings":["Independent Consultant, Independent Consultant, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Independent Consultant, Independent Consultant, PA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074685350","display_name":"Homa B. Dastani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Homa Dastani","raw_affiliation_strings":["Novartis Pharmaceuticals  Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals  Corporation, East Hanover, NJ","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077745682","display_name":"Douglas O. Gause","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglas Gause","raw_affiliation_strings":["Novartis Pharmaceuticals  Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals  Corporation, East Hanover, NJ","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"120","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.007799999788403511,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3611","display_name":"Pharmacy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.8529999852180481},{"id":"https://openalex.org/keywords/single-pill-combination","display_name":"single-pill combination","score":0.6470000147819519},{"id":"https://openalex.org/keywords/valsartan","display_name":"valsartan","score":0.7440000176429749},{"id":"https://openalex.org/keywords/amlodipine","display_name":"amlodipine","score":1.0},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.6819999814033508},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.843999981880188},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.8870000243186951},{"id":"https://openalex.org/keywords/hydrochlorothiazide","display_name":"hydrochlorothiazide","score":0.9819999933242798},{"id":"https://openalex.org/keywords/pill-burden","display_name":"medication burden","score":0.8059999942779541},{"id":"https://openalex.org/keywords/medication-possession-ratio","display_name":"medication possession ratio","score":0.8820000290870667},{"id":"https://openalex.org/keywords/antihypertensive-therapy","display_name":"antihypertensive therapy","score":0.8479999899864197}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.967737078666687},{"id":"https://openalex.org/C2779646130","wikidata":"https://www.wikidata.org/wiki/Q411347","display_name":"Amlodipine","level":3,"score":0.837755560874939},{"id":"https://openalex.org/C2780361556","wikidata":"https://www.wikidata.org/wiki/Q423930","display_name":"Hydrochlorothiazide","level":3,"score":0.700545608997345},{"id":"https://openalex.org/C2777387769","wikidata":"https://www.wikidata.org/wiki/Q155472","display_name":"Valsartan","level":3,"score":0.7003555297851562},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48732027411460876},{"id":"https://openalex.org/C81603835","wikidata":"https://www.wikidata.org/wiki/Q3457430","display_name":"Pill","level":2,"score":0.48166048526763916},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4511014521121979},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.44217634201049805},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.4358067810535431},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.4327632486820221},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.18745610117912292},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:39034895","doi":null,"is_oa":false,"landing_page_url":"http://circ.ahajournals.org/cgi/content/meeting_abstract/120/18_MeetingAbstracts/S522-a","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Circulation","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1002397017","display_name":null,"funder_award_id":"2682021ZTPY012","funder_id":"https://openalex.org/F4320329878","funder_display_name":"Central University Basic Research Fund of China"},{"id":"https://openalex.org/G5380159462","display_name":null,"funder_award_id":"2682024ZTPY014","funder_id":"https://openalex.org/F4320329878","funder_display_name":"Central University Basic Research Fund of China"},{"id":"https://openalex.org/G706936723","display_name":null,"funder_award_id":"22174117","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320329878","display_name":"Central University Basic Research Fund of China","ror":null}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1972965942","https://openalex.org/W1979338300","https://openalex.org/W1984861139","https://openalex.org/W2052696078","https://openalex.org/W2067305929","https://openalex.org/W2795709876","https://openalex.org/W2945487368","https://openalex.org/W3138293032","https://openalex.org/W3215805444","https://openalex.org/W4213138354","https://openalex.org/W4214515840","https://openalex.org/W4224929114","https://openalex.org/W4280643045","https://openalex.org/W4283268036","https://openalex.org/W4293581492","https://openalex.org/W4296817682","https://openalex.org/W4296844473","https://openalex.org/W4309910735","https://openalex.org/W4366602680","https://openalex.org/W4385498173","https://openalex.org/W4385883946","https://openalex.org/W4386400608","https://openalex.org/W4388562610","https://openalex.org/W4389508899"],"related_works":["https://openalex.org/W3125723802","https://openalex.org/W4383897312","https://openalex.org/W2143144396","https://openalex.org/W4285820607","https://openalex.org/W4315707245","https://openalex.org/W2947890957","https://openalex.org/W2981325301","https://openalex.org/W2053816939","https://openalex.org/W2719452709","https://openalex.org/W2030910130"],"abstract_inverted_index":{"Patient":[0],"adherence":[1],"is":[2],"essential":[3],"to":[4,16,79,147],"achieve":[5],"blood":[6],"pressure":[7],"control":[8],"and":[9,32,59,92,116,170,176,204,221,235,242,258,276],"favorable":[10],"patient":[11],"outcomes.":[12],"Our":[13],"objective":[14],"was":[15,66,120,152,228],"compare":[17],"the":[18,71,148,155,162,168,277],"compliance":[19,225,275],"of":[20,28,57,85,128,164,190,271,279],"patients":[21,132,255],"taking":[22,246,256],"a":[23,42,88,268],"single":[24,247,280],"pill":[25,248,272,281],"combination":[26,104,110],"(SPC)":[27],"valsartan+amlodipine":[29,99],"versus":[30],"dual":[31,241,257],"triple":[33,259],"therapy":[34],"with":[35,48,87,93,199],"an":[36,101,107],"angiotensin":[37],"receptor":[38],"blocker":[39,46],"(ARB)":[40],"+":[41],"dihydropyridine":[43],"calcium":[44],"channel":[45],"(CCB)":[47],"or":[49,95,106],"without":[50],"hydrochlorothiazide":[51],"(HCTZ).":[52],"A":[53],"retrospective":[54],"cohort":[55],"study":[56,72,187],"pharmacy":[58],"medical":[60,90],"claims":[61],"(Medstat":[62],"MarketScan":[63],"\u00ae":[64],")":[65],"conducted.":[67],"Patients":[68,245],"included":[69],"in":[70],"were":[73,82,133,181,213,250],"continuously":[74],"insured":[75],"from":[76],"January":[77],"2007":[78,115],"September":[80,117],"2008,":[81],"\u226518":[83],"years":[84,203],"age":[86,201],"hypertension":[89],"claim":[91],"2":[94],"more":[96,252],"fills":[97],"for":[98,141,239],"(\u201cSPC\u201d),":[100],"ARB+CCB":[102],"free":[103,109],"(\u201cdual\u201d)":[105],"ARB+CCB+HCTZ":[108],"(\u201ctriple\u201d)":[111],"concomitantly":[112],"between":[113,167],"July":[114],"2008.":[118],"\u201cConcomitant\u201d":[119],"defined":[121,160],"as":[122,161],"prescriptions":[123,140],"filled":[124],"within":[125],"30":[126],"days":[127],"each":[129],"other.":[130],"All":[131],"initiating":[134],"therapy,":[135],"meaning":[136],"they":[137],"had":[138],"no":[139],"these":[142],"agents":[143],"6":[144],"months":[145],"prior":[146],"first":[149],"fill.":[150],"Compliance":[151],"measured":[153],"using":[154,183],"medication":[156],"possession":[157],"ratio":[158],"(MPR),":[159],"percent":[163],"days\u2019":[165],"supply":[166],"initial":[169],"last":[171],"fill":[172],"dates.":[173],"Descriptive":[174],"statistics":[175],"95%":[177],"Bootstrap":[178],"confidence":[179],"intervals":[180],"calculated":[182],"SAS":[184],"software.":[185],"The":[186,207,262],"population":[188],"consisted":[189],"29,627":[191],"individuals":[192],"(11,588":[193],"SPC,":[194,240],"17,868":[195],"dual,":[196],"171":[197],"triple)":[198],"mean":[200],"61.7":[202],"49%":[205],"female.":[206],"top":[208],"three":[209],"prevalent":[210],"comorbid":[211],"conditions":[212],"ischemic":[214],"heart":[215],"disease":[216,219],"(18.2%),":[217],"cerebrovascular":[218],"(11.3%)":[220],"diabetes":[222],"(4.0%).":[223],"Mean":[224],"(95%":[226],"CI)":[227],"0.85":[229],"(0.84,":[230],"0.85),":[231],"0.63":[232],"(0.63,":[233],"0.64),":[234],"0.54":[236],"(0.51,":[237],"0.58)":[238],"triple,":[243],"respectively.":[244],"combinations":[249],"significantly":[251],"compliant":[253],"than":[254],"antihypertensive":[260],"therapy.":[261],"findings":[263],"support":[264],"existing":[265],"evidence":[266],"suggesting":[267],"negative":[269],"impact":[270],"burden":[273],"on":[274],"value":[278],"combinations.":[282]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W39034895","counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
